Learn
Amino Minder is built around real pharmacokinetic modeling, not just a dose log. These articles go under the hood -- the math behind an absorption curve, how a growth-hormone cascade is modeled, and what real protocol tracking requires that a simple log doesn't.
How Pharmacokinetic Modeling Works: The Real Math Behind an Absorption Curve
The Bateman function, half-life, and how a plasma-level chart is actually calculated -- not a black box.
The MathHalf-Life, Clearance, and Why Your Curve Looks Different From Someone Else's
Why the same dose produces a different curve for different people, and the two numbers that actually drive it.
The MathInside the Cascade: How a GHRH/GHRP Dose Triggers Downstream GH and IGF-1 Response
How GHRH/GHRP-class peptides like Ipamorelin trigger a downstream GH and IGF-1 chain reaction, modeled step by step.
TrackingThe Difference Between a Dose Log and Real Protocol Tracking
A timestamp can't tell you if you're adhering to a protocol. Here's what actually can.
TrackingRoute of Administration and Bioavailability: What Actually Determines Absorption
How route of administration and molecular weight determine how much of a dose actually reaches circulation.
The MathTestosterone + hCG: How This Combination Preserves Fertility on TRT
Why testosterone replacement therapy suppresses natural fertility, how hCG works around that suppression, and what published studies show about the combination.
Evidence CheckBPC-157 + TB-500: What the Evidence Actually Shows (and Doesn't)
The published mechanism research behind BPC-157 and TB-500, and an honest look at how much of it has actually been confirmed in humans.
The MathSermorelin + Ipamorelin: A Different GHRH/GHRP Pairing, and Why the Timing Is the Point
How Sermorelin and Ipamorelin's very different half-lives shape their combined growth hormone effect, and how this pairing differs from CJC-1295 + Ipamorelin.